Long-term safety and efficacy of aficamten in the evolving era of myosin inhibition for obstructive hypertrophic cardiomyopathy.
Saved in:
| Title: | Long-term safety and efficacy of aficamten in the evolving era of myosin inhibition for obstructive hypertrophic cardiomyopathy. |
|---|---|
| Authors: | Lopes LR; St Bartholomew's Hospital, Barts Heart Centre, London, UK.; Institute of Cardiovascular Science, University College London, 16-18 Westmoreland Street, London W1G 8PH, UK. |
| Source: | European heart journal [Eur Heart J] 2026 Jun 23; Vol. 47 (24), pp. 3132-3134. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
